Showing results (141-150 of 145) with videos related to
Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 145 results.
Scientific Reports|April 24, 2025
sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trialDavid M Smadja, Clément R Massonnaud, Aurélien Philippe, et al.The New England Journal of Medicine|April 11, 2020
Compassionate Use of Remdesivir for Patients with Severe Covid-19Jonathan Grein, Norio Ohmagari, Daniel Shin, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 28, 2021
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19Florence Ader, Nathan Peiffer-Smadja, Julien Poissy, et al.Eclinicalmedicine|March 30, 2022
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study groupOlivier Hermine, Xavier Mariette, Raphael Porcher, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 22, 2025
Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in hospitalized COVID-19 patients: long-term results from the DisCoVeRy trialClément R Massonnaud, Nathan Peiffer-Smadja, Pascal Poignard, et al.Pageof 15